The value of method of use patent claims in protecting your therapeutic assets

This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted at [email protected]. When it comes to protecting therapeutic assets, I have long advocated for the value of method of use (MOU) and other complementary patent claims for protecting therapeutic assets. Such claims hold significant value, […] Source